TAF is a novel, targeted prodrug of tenofovir that has demonstrated high antiviral efficacy similar to Gilead’s Viread® 245 mg of tenofovir disoproxil (as fumarate) (TDF) at one-tenth
Growing evidence has suggested high levels of intense exercise may actually damage your heart causing permanent structural changes resulting in an abnormal heart rhythm. A review published in
"Receiving orphan drug status in the EU is another encouraging step in the development of RE-024 for the treatment of PKAN," said Alvin Shih, M.D., executive vice president
This filing will add important new clinical data to the current label from two Phase 3 trials evaluating the safety and efficacy of AVYCAZ, in combination with metronidazole,
Results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Data from the study support the advancement of cabotegravir, an integrase strand transfer inhibitor,
The 60 year-old, from the University Of Michigan Frankel Cardiovascular Center, is one of the busiest mitral valve surgeons in the country fixing faulty heart valves when he
Pfizer claims that the drug is the first once-daily oral RA treatment in its class of Janus kinase (JAK) inhibitors. Xeljanz is indicated to treat adults with moderately
The research project will assess the feasibility of using a novel, patent-pending lymph directing drug delivery technology. The technology was developed by researchers at the ARC Centre of
Under the terms of the agreement, Neon Therapeutics and NKI will combine complementary capabilities to develop personalized T cell therapeutics. The work will leverage the research by John
At Week 48, the F/TAF-based regimens were found to be statistically non-inferior to the F/TDF-based regimens, based on percentages of patients with HIV-1 RNA levels less than 50
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.